Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.8M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
6.8M
-
Shares change
-
+836K
-
Total reported value, excl. options
-
$37.1M
-
Value change
-
+$4.61M
-
Number of buys
-
33
-
Number of sells
-
-7
-
Price
-
$5.45
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q2 2020
42 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q2 2020.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.8M shares
of 26.8M outstanding shares and own 25.36% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (3.64M shares), AWM Investment Company, Inc. (803K shares), BlackRock Inc. (701K shares), VANGUARD GROUP INC (358K shares), Diametric Capital, LP (230K shares), PRELUDE CAPITAL MANAGEMENT, LLC (156K shares), STATE STREET CORP (151K shares), GEODE CAPITAL MANAGEMENT, LLC (106K shares), Westside Investment Management, Inc. (82.1K shares), and ROYAL BANK OF CANADA (60.2K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.